Search details
1.
Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study.
Br J Cancer
; 129(4): 620-625, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37422527
2.
Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
Am J Otolaryngol
; 43(1): 103193, 2022.
Article
in English
| MEDLINE | ID: mdl-34509080
3.
Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.
Am J Otolaryngol
; 43(1): 103235, 2022.
Article
in English
| MEDLINE | ID: mdl-34563802
4.
Prognostic nomogram to predict the overall survival of patients with early-onset colorectal cancer: a population-based analysis.
Int J Colorectal Dis
; 36(9): 1981-1993, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34322745
5.
A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy.
J Hepatocell Carcinoma
; 11: 219-228, 2024.
Article
in English
| MEDLINE | ID: mdl-38293613
6.
Development and Validation of Deep Learning Model for Intermediate-Stage Hepatocellular Carcinoma Survival with Transarterial Chemoembolization (MC-hccAI 002): a Retrospective, Multicenter, Cohort Study.
J Cancer
; 15(7): 2066-2073, 2024.
Article
in English
| MEDLINE | ID: mdl-38434985
7.
Postoperative subphenotypes modified the hepatoma arterial-embolization prognostic score: A novel smHAP-II nomogram.
J Cancer
; 15(10): 2940-2947, 2024.
Article
in English
| MEDLINE | ID: mdl-38706898
8.
Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study.
Front Oncol
; 14: 1327691, 2024.
Article
in English
| MEDLINE | ID: mdl-38444686
9.
Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort study.
Lancet Reg Health West Pac
; 45: 101031, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38361774
10.
Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score.
J Hepatocell Carcinoma
; 10: 1341-1351, 2023.
Article
in English
| MEDLINE | ID: mdl-37588889
11.
Clinical models to predict lymph nodes metastasis and distant metastasis in newly diagnosed early esophageal cancer patients: A population-based study.
Cancer Med
; 12(5): 5275-5292, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36205033
12.
The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study.
J Cancer
; 14(8): 1272-1281, 2023.
Article
in English
| MEDLINE | ID: mdl-37283795
13.
Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma.
Cancer Biomark
; 37(1): 1-11, 2023.
Article
in English
| MEDLINE | ID: mdl-36938724
14.
Readjustment of nodal staging by integrating tumor deposits and positive lymph nodes in patients with stage III colon cancer: a population-based analysis.
Am J Cancer Res
; 13(10): 4976-4988, 2023.
Article
in English
| MEDLINE | ID: mdl-37970348
15.
DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation.
Cancer Biol Med
; 21(3)2023 Dec 29.
Article
in English
| MEDLINE | ID: mdl-38164720
16.
Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study.
EClinicalMedicine
; 47: 101391, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35480077
17.
Latent Class Analysis of Subphenotypes in Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization.
J Cancer
; 13(12): 3318-3325, 2022.
Article
in English
| MEDLINE | ID: mdl-36186899
18.
Decision curve analysis to identify optimal candidates of liver resection for intermediate-stage hepatocellular carcinoma with hepatitis B cirrhosis: A cohort study.
Medicine (Baltimore)
; 101(43): e31325, 2022 Oct 28.
Article
in English
| MEDLINE | ID: mdl-36316942
19.
Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virus-associated gastric cancer.
Front Immunol
; 13: 1003859, 2022.
Article
in English
| MEDLINE | ID: mdl-36353623
20.
Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study.
Front Oncol
; 11: 618937, 2021.
Article
in English
| MEDLINE | ID: mdl-34778022